Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 313

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Transcatheter treatment for tricuspid valve disease

Open access
Praz, Fabien, Muraru, Denisa, Kreidel, Felix, Lurz, Philipp, Hahn, Rebecca T., Delgado, Victoria, Senni, Michele, von Bardeleben, Ralph Stephan, Nickenig, Georg, Hausleiter, Jörg, Mangieri, Antonio, Zamorano, Jose L., Prendergast, Bernard D., Maisano, Francesco·2021·EuroIntervention

Abstract

Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid regurgitation (TR).Primary TR results from anatomical abnormality of the tricuspid valve apparatus and is observed in only 8-10% of the patients with tricuspid valve disease.Secondary TR is more common and arises as a result of annular dilation caused by right ventricular enlargement and dysfunction as a consequence of pulmonary hypertension, often caused by left-sided heart disease or atrial fibrillation.Irrespective of its aetiology, TR leads to volume overload and increased wall stress, both of which negatively contribute to detrimental remodelling and worsening TR.This vicious circle translates into impaired survival and increased heart failure symptoms in patients with and without reduced left ventricular ejection fraction.Interventions to correct TR are underutilised in daily clinical practice owing to increased surgical risk and late patient presentation.The recently introduced transcatheter tricuspid valve interventions aim to address this unmet need.Dedicated expertise and an interdisciplinary Heart Team evaluation are essential to integrate these new techniques successfully and select patients.The present article proposes a standardised approach to evaluate patients with TR who may be candidates for transcatheter interventions.In addition, a state-of-the-art review of the available transcatheter therapies, the main criteria for patient and device selection, and information concerning the remaining uncertainties are provided. 2Dtwo-dimensional 3D three-dimensional AF atrial fibrillation CCT cardiac computed tomography CIED cardiac implantable electronic device CMR cardiac magnetic resonance EROA effective regurgitant orifice area HF heart failure NOAC non-vitamin K antagonist oral anticoagulants PHT pulmonary hypertension SPAP systolic pulmonary artery pressure STR secondary tricuspid regurgitation TAPSE tricuspid annular plane systolic excursion TEE transoesophageal echocardiography TR tricuspid regurgitation TTE transthoracic echocardiography T-TEER tricuspid transcatheter edge-to-edge repair TTVI transcatheter tricuspid valve intervention TTVR transcatheter tricuspid valve replacement TV tricuspid valve

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4244/eij-d-21-00695

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 313

Metadata

Authors
Praz, F., Muraru, D., Kreidel, F., Lurz, P., Hahn, R. T., Delgado, V., Senni, M., von Bardeleben, R. S., Nickenig, G., Hausleiter, J., Mangieri, A., Zamorano, J. L., Prendergast, B. D., & Maisano, F.
Venue
EuroIntervention
Published
2021-11
Volume
17
Issue
10
Pages
791-808
ISSN
1774-024X (ISSN-L)
OpenAlex
W3212684942
Cited by
313
References
70
FWCI
31.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcatheter treatment for tricuspid valve disease. https://app.cochat.ai/papers/10.4244/eij-d-21-00695
The paper
Praz, F., Muraru, D., Kreidel, F., Lurz, P., Hahn, R. T., Delgado, V., Senni, M., von Bardeleben, R. S., Nickenig, G., Hausleiter, J., Mangieri, A., Zamorano, J. L., Prendergast, B. D., & Maisano, F. (2021). Transcatheter treatment for tricuspid valve disease. EuroIntervention. https://doi.org/10.4244/eij-d-21-00695

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.